EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,609,000 | +390.3% | 49,611 | +373.0% | 0.00% | – |
| Q4 2020 | $940,000 | -97.5% | 10,488 | -97.1% | 0.00% | -100.0% |
| Q3 2020 | $37,011,000 | +83.5% | 358,178 | +40.4% | 0.01% | +100.0% |
| Q2 2020 | $20,174,000 | +5647.6% | 255,117 | +4100.8% | 0.00% | – |
| Q1 2020 | $351,000 | -86.1% | 6,073 | -87.0% | 0.00% | -100.0% |
| Q4 2019 | $2,530,000 | +46.3% | 46,891 | +78.6% | 0.00% | – |
| Q3 2018 | $1,729,000 | -70.1% | 26,262 | -77.1% | 0.00% | -100.0% |
| Q2 2018 | $5,791,000 | +8.1% | 114,692 | +12.7% | 0.00% | 0.0% |
| Q1 2018 | $5,357,000 | +33.9% | 101,750 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $4,000,000 | +353.5% | 86,063 | +294.9% | 0.00% | – |
| Q3 2017 | $882,000 | +19.4% | 21,795 | 0.0% | 0.00% | – |
| Q2 2017 | $739,000 | -41.4% | 21,795 | -49.9% | 0.00% | – |
| Q1 2017 | $1,262,000 | -61.7% | 43,470 | -56.7% | 0.00% | -100.0% |
| Q4 2016 | $3,295,000 | -38.6% | 100,322 | -41.1% | 0.00% | 0.0% |
| Q3 2016 | $5,369,000 | +16.9% | 170,260 | +4.2% | 0.00% | 0.0% |
| Q2 2016 | $4,594,000 | -32.8% | 163,353 | -13.2% | 0.00% | -50.0% |
| Q1 2016 | $6,839,000 | -11.5% | 188,150 | -2.6% | 0.00% | 0.0% |
| Q4 2015 | $7,732,000 | +81.0% | 193,243 | +28.9% | 0.00% | +100.0% |
| Q3 2015 | $4,271,000 | +24.4% | 149,943 | +43.9% | 0.00% | 0.0% |
| Q2 2015 | $3,433,000 | +141.8% | 104,176 | +111.0% | 0.00% | – |
| Q1 2015 | $1,420,000 | +26.9% | 49,361 | +20.1% | 0.00% | – |
| Q4 2014 | $1,119,000 | -32.6% | 41,095 | -47.2% | 0.00% | – |
| Q3 2014 | $1,660,000 | -11.1% | 77,900 | -6.4% | 0.00% | -100.0% |
| Q2 2014 | $1,868,000 | -63.5% | 83,188 | -58.9% | 0.00% | 0.0% |
| Q1 2014 | $5,111,000 | +17.5% | 202,288 | +6.9% | 0.00% | 0.0% |
| Q4 2013 | $4,350,000 | +44.7% | 189,188 | +19.9% | 0.00% | 0.0% |
| Q3 2013 | $3,006,000 | +93.2% | 157,788 | +46.3% | 0.00% | 0.0% |
| Q2 2013 | $1,556,000 | – | 107,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |